Catalyst Wire Dossier Catalyst Wire Dossier

Peginterferon alfa-2b (PegIntron)

peginterferon alfa-2b · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peginterferon alfa-2b (PegIntron), covering 2014-08-13 to 2014-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) [Phase 3]

See pricing